Abstract
These studies were undertaken to elucidate the mechanisms whereby the cytokine, Interleukin (IL-1) suppresses pituitary LH release in orchidectomized rats. Since LH secretion in pulsatile in castrated rats, the effects of IL-1 on the components of the LH pulsatility were assessed. Intracerebroventricular (i.c.v.) administration of IL-1α or IL-1β suppressed LH release, but IL-1β was relatively more effective than IL-1α in terms of the onset (IL-1β = 30min; IL-1α = 105min) as welk as the magnitude and duration of LH suppression. Further, the marked suppression of LH secretion in IL-1β-treated rats was found to be due to significant reductions both in the frequency and amplitude of LH episodes. We next evaluated whether the IL-1β-induced suppression of LH release was mediated by either of the two inhibitory hypothalamic peptidergic systems, corticotrophin releasing hormone (CRH) and endogenous opioid peptides (EOP). Passive immunoneutralization of CRH by i.c.v. administration of a specific CRH-antibody, either once at 15 min or twice at 75 and 15 min before IL-1β injection, failed to block the suppressive effects of IL-1β on LH release. Similarly, pharmacological blockade of CRH by i.c.v. injection of the CRH receptor antagonist, α-helical CRH 9–41 15 min before IL-1β was ineffective. However, i.v. infusion of the opiate receptor antagonist, naloxone, which on its own had no effect on LH secretion, counteracted the inhibitory effects of IL-1β. To further identify the opiate receptor subtype involved, we utilized specific opiate receptor subtype antagonists. We observed that neither blockade of δ receptors with naltrindole, nor blockade of κ receptors with nor-binaltorphimine dihydrochloride, altered the course of LH suppression seen after IL-1β injection. However, prior blockade ofμ 1 opiate receptors wit β-funaltrexamine hydrochloride, completely reversed the inhibitory effects of IL-1β on LH release. These results show that IL-1β suppresses both the frequency and amplitude of LH discharge in two-week castrated rats. Further pharmacologic evidence shows that IL-1ß-induced suppression of LH secretion may involve stimulation of hypothalamic endogenous opioids which presumably act via the hypothalamicμ 1 opiate receptor subtype, and that stimulation of hypothalamic CRH release may not be essential in manifestation of the inhibitory effects of IL-1ß on LH release.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.